Rrd1 isomerizes RNA polymerase II in response to rapamycin
2010

Rrd1's Role in RNA Polymerase II Isomerization and Response to Rapamycin

publication Evidence: moderate

Author Information

Author(s): Nathalie Jouvet, Jeremie Poschmann, Julie Douville, Lisa Bulet, Dindial Ramotar

Primary Institution: Maisonneuve-Rosemont Hospital, Research Center, Department of Immunology and Oncology, University of Montreal

Hypothesis

How does Rrd1 activity link to the biological responses in yeast when exposed to rapamycin?

Conclusion

Rrd1 isomerizes RNA polymerase II to promote its dissociation from chromatin, modulating transcription in response to rapamycin.

Supporting Evidence

  • Rrd1 is associated with chromatin and interacts with RNA polymerase II.
  • Rrd1 mediates structural changes in RNA polymerase II's C-terminal domain in response to rapamycin.
  • Rrd1 is required to alter RNA polymerase II occupancy on rapamycin-responsive genes.

Takeaway

Rrd1 helps a protein called RNA polymerase II change shape so it can let go of DNA when the yeast is stressed by a drug called rapamycin.

Methodology

The study involved genetic analysis, co-immunoprecipitation, chromatin extraction, and circular dichroism spectroscopy to assess Rrd1's role.

Limitations

The study primarily focuses on yeast, which may limit the applicability of findings to other organisms.

Digital Object Identifier (DOI)

10.1186/1471-2199-11-92

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication